Evidence map›Paper›PMID 36311535›Full record

ArticleFrontiers in psychiatry2022

Role of leukocytes, gender, and symptom domains in the influence of depression on hospitalization and mortality risk: Findings from the Moli-sani study.

Alessandro Gialluisi, Francesca Bracone, Simona Costanzo, Federica Santonastaso, Augusto Di Castelnuovo, Sabatino Orlandi, Sara Magnacca, Amalia De Curtis, Chiara Cerletti, Maria Benedetta Donati and 2 more

Abstract read
In one paragraph

Article in Frontiers in psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Alessandro GialluisiEPIMED Research Center, Department of Medicine and Surgery, University of Insubria, Varese, Italy.
Francesca BraconeDepartment of Epidemiology and Prevention, IRCCS NEUROMED, Pozzilli, Italy.
Simona CostanzoDepartment of Epidemiology and Prevention, IRCCS NEUROMED, Pozzilli, Italy.
Federica SantonastasoEPIMED Research Center, Department of Medicine and Surgery, University of Insubria, Varese, Italy.
Augusto Di CastelnuovoMediterranea Cardiocentro, Napoli, Italy.
Sabatino OrlandiDepartment of Epidemiology and Prevention, IRCCS NEUROMED, Pozzilli, Italy.
Sara MagnaccaMediterranea Cardiocentro, Napoli, Italy.
Amalia De CurtisDepartment of Epidemiology and Prevention, IRCCS NEUROMED, Pozzilli, Italy.
Chiara CerlettiDepartment of Epidemiology and Prevention, IRCCS NEUROMED, Pozzilli, Italy.
Maria Benedetta DonatiDepartment of Epidemiology and Prevention, IRCCS NEUROMED, Pozzilli, Italy.
Giovanni de GaetanoDepartment of Epidemiology and Prevention, IRCCS NEUROMED, Pozzilli, Italy.
Licia IacovielloEPIMED Research Center, Department of Medicine and Surgery, University of Insubria, Varese, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Major depressive disorder is a mental illness associated with chronic conditions like cardiovascular disease (CVD). Circulating inflammation has been proposed as a potential mechanism underlying this link, although the role of specific biomarkers, gender, and symptom domains is not well elucidated. Methods: We performed multivariable Cox regressions of first hospitalization/all-cause mortality and CVD, ischemic heart (IHD), and cerebrovascular disease (CeVD) causes vs. depression severity in an Italian population cohort ( Results: Significant proportions of the influence of depression on clinical risks were explained by CRP (4.8% on IHD hospitalizations), GLR (11% on all-cause mortality), and WBC (24% on IHD/CeVD hospitalizations). Gender-by-depression interaction was significantly associated only with all-cause mortality ( Conclusions: These findings highlight the importance of cellular components of inflammation, gender, and somatic depressive symptoms in the link between depression and clinical (especially CVD) risks, pointing to the existence of additional pathways through which depression may play a detrimental effect on the cardiovascular system.

Indexed as

cardiovascular diseaseC-reactive proteindepressiongranulocyteshospitalizationsinflammationlymphocytesmortality

Identifiers

PMID36311535
PMCPMC9606761

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.